Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey D Rothstein

Showing results (171-180 of 215) with videos related to

Pageof 22
Sort By:
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Functional Activity of TDP-43: A Direct Biomarker for ALSKirti Shila Sonkar, Vito Levi D'Ancona, Jade Cramp, et al.
Brain : a Journal of Neurology|April 12, 2024
Apilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trialSuma Babu, Katharine A Nicholson, Jeffrey D Rothstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 10, 2006
Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor traffickingChen Lai, Chengsong Xie, Stefanie G McCormack, et al.
Nature Neuroscience|December 10, 2013
Identification of a unique TGF-β-dependent molecular and functional signature in microgliaOleg Butovsky, Mark P Jedrychowski, Craig S Moore, et al.
Plos One|April 25, 2013
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosisJames D Berry, Jeremy M Shefner, Robin Conwit, et al.
The Lancet. Neurology|October 10, 2014
Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trialMerit E Cudkowicz, Sarah Titus, Marianne Kearney, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2016
Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutationsNhat T T Le, Lydia Chang, Irina Kovlyagina, et al.
Frontiers in Aging Neuroscience|July 15, 2022
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics - An AI-Enabled Biological Target Discovery PlatformFrank W Pun, Bonnie Hei Man Liu, Xi Long, et al.
Nature Neuroscience|April 3, 2019
Molecularly defined cortical astroglia subpopulation modulates neurons via secretion of NorrinSean J Miller, Thomas Philips, Namho Kim, et al.
Science Translational Medicine|December 21, 2012
Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysisYang D Teng, Susanna C Benn, Steven N Kalkanis, et al.
Pageof 22

Showing results (171-180 of 215) with videos related to

Sort By:
Pageof 22
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Functional Activity of TDP-43: A Direct Biomarker for ALSKirti Shila Sonkar, Vito Levi D'Ancona, Jade Cramp, et al.
Brain : a Journal of Neurology|April 12, 2024
Apilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trialSuma Babu, Katharine A Nicholson, Jeffrey D Rothstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 10, 2006
Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor traffickingChen Lai, Chengsong Xie, Stefanie G McCormack, et al.
Nature Neuroscience|December 10, 2013
Identification of a unique TGF-β-dependent molecular and functional signature in microgliaOleg Butovsky, Mark P Jedrychowski, Craig S Moore, et al.
Plos One|April 25, 2013
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosisJames D Berry, Jeremy M Shefner, Robin Conwit, et al.
The Lancet. Neurology|October 10, 2014
Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trialMerit E Cudkowicz, Sarah Titus, Marianne Kearney, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2016
Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutationsNhat T T Le, Lydia Chang, Irina Kovlyagina, et al.
Frontiers in Aging Neuroscience|July 15, 2022
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics - An AI-Enabled Biological Target Discovery PlatformFrank W Pun, Bonnie Hei Man Liu, Xi Long, et al.
Nature Neuroscience|April 3, 2019
Molecularly defined cortical astroglia subpopulation modulates neurons via secretion of NorrinSean J Miller, Thomas Philips, Namho Kim, et al.
Science Translational Medicine|December 21, 2012
Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysisYang D Teng, Susanna C Benn, Steven N Kalkanis, et al.
Pageof 22